Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Vomiting × fosaprepitant × Clear all

Phase

Phase 2 4 Phase NA 3 Phase 4 2 Phase 3 2 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 1 Nausea 1 Nasopharyngeal Carcinoma 1 Breast Neoplasms 1

Interventions

Granisetron 5 casopitant 2 Cyclophosphamide 2 fosaprepitant 1 Tablets 1 Methadone 1 Injections, Intravenous 1 Dronabinol 1 Docetaxel 1 Cannabidiol 1 Aprepitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01649258 2017-11-17

Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy

University of Southern California

Phase 1 Terminated

Breast Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡